Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Ventricular Tachycardia After Cardioversion
Author(s): Eiad Habib , Mahmoud Abdelnabi , Ramzi Ibrahim , et al Added: 2 months ago

Electrophysiology & Arrhythmia

Heart Failure
Ventricular Tachycardia Ablation: Meta-analysis of Randomised Trials
Author(s): Rohin K Reddy , James P Howard , Yousif Ahmad , et al Added: 2 years ago

Electrophysiology & Arrhythmia
Dynamic Voltage Mapping of Ventricular Tachycardia Substrate
Author(s): Mark T Mills , Peter Calvert , Justin Chiong , et al Added: 1 year ago

Electrophysiology & Arrhythmia
Functional Substrate Mapping
Author(s): Jaffar Al-Sheikhli , Patrick Tran , Rafaella Siang , et al Added: 1 year ago

Electrophysiology & Arrhythmia
HRS 25: FIH VCAS Trial
Author(s): Vivek Reddy Added: 9 months ago
HRS 25 - First-in-human data from the FIH VCAS trial suggests the FieldForce Ablation system can effectively create transmural ablation lesions in patients with scar-related ventricular tachycardia (VT), with an 80% freedom from VT and ventricular fibrillation rate at 6 months.We are joined by Dr Vivek Reddy (Mount Sinai Hospital, New York, US) to discuss the findings from the prospective, first… View more

Electrophysiology & Arrhythmia
New Insights into VT Substrate Identification
Author(s): Pier D Lambiase Added: 10 months ago
EHRA 2025 - We are joined onsite at EHRA Congress 2025 by Prof Pier Lambiase to discuss the latest developments in ventricular tachycardia substrate identification from the EHRA Ablation Summit 2025.Interview Questions:What are the key challenges or limitations that still exist in accurately identifying VT substrates?What are the most significant recent advancements in techniques or technologies… View more

Electrophysiology & Arrhythmia
Ablation Beats Sotalol for VT in VANISH2 Substudy
Added: 3 days ago Source:  Arrhythmia Academy
A new substudy of the VANISH2 trial suggests that for patients with prior myocardial infarction and ventricular tachycardia (VT) who are eligible for sotalol, catheter ablation leads to better outcomes than antiarrhythmic drug (AAD) therapy.¹ For patients eligible only for amiodarone, efficacy was comparable, but amiodarone was associated with a significant increase in adverse events… View more

Electrophysiology & Arrhythmia

MI/ACS
Ablation vs Drugs for VT: Insights from VANISH2
Added: 2 weeks ago Source:  Radcliffe Cardiology
A prespecified substudy of the VANISH2 trial suggests first-line catheter ablation is superior to sotalol for reducing arrhythmia events in eligible patients with ischaemic cardiomyopathy and ventricular tachycardia (VT).¹ In patients ineligible for sotalol, ablation showed comparable efficacy to amiodarone but with a markedly better long-term safety profile.MethodologyThe VANISH2 (Ventricular… View more

Electrophysiology & Arrhythmia

Heart Failure
Rhythm Interventions Online 2022 – Case Retrospective: HD Grid Mapping in Complex VT
Author(s): Roderick Tung Added: 2 years ago
Following the success of Rhythm Interventions Online 2022 (30 November – 2 December 2022), here Course Co-director and operator Dr Roderick Tung reviews his HD Grid Mapping in Complex VT case performed live at the event. Includes comment and insight from fellow course leaders Prof Richard Schilling(St Bartholomew's Hospital, London, UK), Prof Julian Chun(CCB Markus Krankenhaus, Frankfurt, DE)… View more

Electrophysiology & Arrhythmia
Peripheral Sympathetic Neuromodulation for Ventricular Arrhythmias
Author(s): Léa Benabou , Marmar Vaseghi Added: 1 month ago

Electrophysiology & Arrhythmia